Jeremy Grantham’s HUM Holdings & Trades

First Buy
Q2 2013
Duration Held
50 Quarters
Largest Add
Q1 2014
+732,273 Shares
Current Position
42,220 Shares
$10.98 M Value

Jeremy Grantham's HUM Position Overview

Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 42,220 shares of Humana Inc. (HUM) worth $10.98 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.

Based on 13F filings since 2013, Jeremy Grantham has maintained a long-term strategic position in HUM, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2014, adding 732,273 shares. Largest reduction occurred in Q1 2016, reducing 385,300 shares.

Analysis based on 13F filings available since 2013 Q2

Jeremy Grantham's Humana (HUM) Holding Value Over Time

Track share changes against reported price movement

Quarterly Humana (HUM) Trades by Jeremy Grantham

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2013 +134,540 Add 0.00% 134,539 $84.38
Q3 2013 +5,565 Add 4.14% 140,104 $93.33
Q4 2013 +32,180 Add 22.97% 172,284 $103.22
Q1 2014 +732,273 Add 425.04% 904,557 $112.72
Q2 2014 +120,400 Add 13.31% 1.02 M $127.72
Q3 2014 +100,996 Add 9.85% 1.13 M $130.29
Q4 2014 -18,999 Reduce 1.69% 1.11 M $143.63
Q1 2015 -132,889 Reduce 12.00% 974,065 $178.02
Q2 2015 -38,300 Reduce 3.93% 935,765 $191.28
Q3 2015 +431,607 Add 46.12% 1.37 M $179.00
Q4 2015 -238,693 Reduce 17.46% 1.13 M $178.51
Q1 2016 -385,300 Reduce 34.14% 743,379 $182.95
Q2 2016 -87,597 Reduce 11.78% 655,782 $179.88
Q3 2016 -6,245 Reduce 0.95% 649,537 $176.89
Q4 2016 -86,223 Reduce 13.27% 563,314 $204.03
Q1 2017 -131,453 Reduce 23.34% 431,861 $206.14
Q2 2017 +137,248 Add 31.78% 569,109 $240.62
Q3 2017 -37,434 Reduce 6.58% 531,675 $243.63
Q4 2017 -38,424 Reduce 7.23% 493,251 $248.07
Q1 2018 -321,636 Reduce 65.21% 171,615 $268.83
Q2 2018 -171,615 Sold Out 171,615 $0.00
Q4 2018 +24,600 New Buy 24,600 $286.46
Q1 2019 +3,100 Add 12.60% 27,700 $265.99
Q2 2019 -27,700 Sold Out 27,700 $0.00
Q4 2019 +360,505 New Buy 360,505 $366.52
Q1 2020 -285,920 Reduce 79.31% 74,585 $314.02
Q2 2020 -74,585 Sold Out 74,585 $0.00
Q2 2022 +2,400 New Buy 2,400 $467.92
Q3 2022 +11,900 Add 495.83% 14,300 $485.17
Q4 2022 -2,500 Reduce 17.48% 11,800 $512.19
Q1 2023 -4,200 Reduce 35.59% 7,600 $485.46
Q2 2023 -877 Reduce 11.54% 6,723 $447.13
Q3 2023 +22,760 Add 338.54% 29,483 $486.52
Q4 2023 +2,955 Add 10.02% 32,438 $457.81
Q1 2024 +16,837 Add 51.91% 49,275 $346.72
Q2 2024 +4,524 Add 9.18% 53,799 $373.65
Q3 2024 -37,287 Reduce 69.31% 16,512 $316.74
Q4 2024 +23,853 Add 144.46% 40,365 $253.71
Q1 2025 +6,438 Add 15.95% 46,803 $264.60
Q2 2025 +591 Add 1.26% 47,394 $244.48
Q3 2025 -5,174 Reduce 10.92% 42,220 $260.17

Jeremy Grantham's Humana Investment FAQs

Jeremy Grantham first purchased Humana Inc. (HUM) in Q2 2013, acquiring 134,539 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham has held Humana Inc. (HUM) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham's largest addition to Humana Inc. (HUM) was in Q1 2014, adding 904,557 shares worth $101.96 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 42,220 shares of Humana Inc. (HUM), valued at approximately $10.98 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Humana Inc. (HUM) represents approximately 0.03% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham's peak holding in Humana Inc. (HUM) was 1,367,372 shares, as reported at the end of Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.